The focus is mainly, but, not solely, on longitudinal randomised controlled
clinical trials. The paper aims to delineate the role of frailty in the modern
analysis of such trials and also in longitudinal survival studies. Our approach exploits
recent developments in statistical modelling and in estimation methods, for
example, in non-PH survival modelling, covariance modelling and in h-likelihood
inference. We illustrate our approach and findings with examples from the literature.
History
Publication
28th International Workshop on Statistical Modelling;